Skip to main content
SpringerLink
Log in

Mitochondrial Genome Changes as Cancer Biomarkers in Circulation

  • Chapter
  • First Online:
Cancer Biomarkers in Body Fluids

  • 955 Accesses

Abstract

Features of mitochondrial genome (mtgenome)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Nass S, Nass MM. Intramitochondrial fibers with DNA characteristics. Ii. Enzymatic and other hydrolytic treatments. J Cell Biol. 1963;19:613–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Nass MM, Nass S. Intramitochondrial fibers with DNA characteristics. I. Fixation and electron staining reactions. J Cell Biol. 1963;19:593–611.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290:457–65.

    Article  CAS  PubMed  Google Scholar 

  4. Clayton DA, Vinograd J. Complex mitochondrial DNA in leukemic and normal human myeloid cells. Proc Natl Acad Sci USA. 1969;62:1077–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Horton TM, Petros JA, Heddi A, et al. Novel mitochondrial DNA deletion found in a renal cell carcinoma. Genes Chromosomes Cancer. 1996;15:95–101.

    Article  CAS  PubMed  Google Scholar 

  6. Ishikawa K, Hashizume O, Koshikawa N, et al. Enhanced glycolysis induced by mtDNA mutations does not regulate metastasis. FEBS Lett. 2008;582:3525–30.

    Article  CAS  PubMed  Google Scholar 

  7. Kulawiec M, Owens KM, Singh KK. Cancer cell mitochondria confer apoptosis resistance and promote metastasis. Cancer Biol Ther. 2009;8:1378–85.

    Article  CAS  PubMed  Google Scholar 

  8. Goh J, Enns L, Fatemie S, et al. Mitochondrial targeted catalase suppresses invasive breast cancer in mice. BMC Cancer. 2011;11:191.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Sotgia F, Whitaker-Menezes D, Martinez-Outschoorn UE, et al. Mitochondrial metabolism in cancer metastasis: visualizing tumor cell mitochondria and the “reverse Warburg effect” in positive lymph node tissue. Cell Cycle. 2012;11:1445–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Witkiewicz AK, Whitaker-Menezes D, Dasgupta A, et al. Using the “reverse Warburg effect” to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers. Cell Cycle. 2012;11:1108–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Chen XH, Bao YY, Zhou SH, et al. Glucose transporter-1 expression in CD133+ laryngeal carcinoma Hep-2 cells. Mol Med Rep. 2013;8:1695–700.

    CAS  PubMed  Google Scholar 

  12. Dakubo GD. Mitochondrial genetics and cancer. Berlin: Springer; 2010.

    Book  Google Scholar 

  13. Fliss MS, Usadel H, Caballero OL, et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science. 2000;287:2017–9.

    Article  CAS  PubMed  Google Scholar 

  14. Polyak K, Li Y, Zhu H, et al. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet. 1998;20:291–3.

    Article  CAS  PubMed  Google Scholar 

  15. Takeuchi H, Fujimoto A, Hoon DS. Detection of mitochondrial DNA alterations in plasma of malignant melanoma patients. Ann N Y Acad Sci. 2004;1022:50–4.

    Article  CAS  PubMed  Google Scholar 

  16. Hibi K, Nakayama H, Yamazaki T, et al. Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients. Int J Cancer. 2001;94:429–31.

    Article  CAS  PubMed  Google Scholar 

  17. Nomoto S, Yamashita K, Koshikawa K, et al. Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma. Clin Cancer Res. 2002;8:481–7.

    CAS  PubMed  Google Scholar 

  18. Okochi O, Hibi K, Uemura T, et al. Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients. Clin Cancer Res. 2002;8:2875–8.

    CAS  PubMed  Google Scholar 

  19. Jeronimo C, Nomoto S, Caballero OL, et al. Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene. 2001;20:5195–8.

    Article  CAS  PubMed  Google Scholar 

  20. Ellinger J, Muller SC, Wernert N, et al. Mitochondrial DNA in serum of patients with prostate cancer: a predictor of biochemical recurrence after prostatectomy. BJU Int. 2008;102:628–32.

    Article  PubMed  Google Scholar 

  21. Mehra N, Penning M, Maas J, et al. Circulating mitochondrial nucleic acids have prognostic value for survival in patients with advanced prostate cancer. Clin Cancer Res. 2007;13:421–6.

    Article  CAS  PubMed  Google Scholar 

  22. Ellinger J, Albers P, Perabo FG, et al. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer. J Urol. 2009;182:324–9.

    Article  CAS  PubMed  Google Scholar 

  23. Zachariah RR, Schmid S, Buerki N, et al. Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors. Obstet Gynecol. 2008;112:843–50.

    Article  CAS  PubMed  Google Scholar 

  24. Masayesva BG, Mambo E, Taylor RJ, et al. Mitochondrial DNA content increase in response to cigarette smoking. Cancer Epidemiol Biomarkers Prev. 2006;15:19–24.

    Article  CAS  PubMed  Google Scholar 

  25. Kim MM, Clinger JD, Masayesva BG, et al. Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions. Clin Cancer Res. 2004;10:8512–5.

    Article  CAS  PubMed  Google Scholar 

  26. Jiang WW, Masayesva B, Zahurak M, et al. Increased mitochondrial DNA content in saliva associated with head and neck cancer. Clin Cancer Res. 2005;11:2486–91.

    Article  CAS  PubMed  Google Scholar 

  27. Jiang WW, Rosenbaum E, Mambo E, et al. Decreased mitochondrial DNA content in posttreatment salivary rinses from head and neck cancer patients. Clin Cancer Res. 2006;12:1564–9.

    Article  CAS  PubMed  Google Scholar 

  28. Zhou S, Kachhap S, Sun W, et al. Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc Natl Acad Sci USA. 2007;104:7540–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Mithani SK, Smith IM, Zhou S, et al. Mitochondrial resequencing arrays detect tumor-specific mutations in salivary rinses of patients with head and neck cancer. Clin Cancer Res. 2007;13:7335–40.

    Article  CAS  PubMed  Google Scholar 

  30. Ballinger SW, Bouder TG, Davis GS, et al. Mitochondrial genome damage associated with cigarette smoking. Cancer Res. 1996;56:5692–7.

    CAS  PubMed  Google Scholar 

  31. Jakupciak JP, Maragh S, Markowitz ME, et al. Performance of mitochondrial DNA mutations detecting early stage cancer. BMC Cancer. 2008;8:285.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Isaacs C, Cavalli LR, Cohen Y, et al. Detection of LOH and mitochondrial DNA alterations in ductal lavage and nipple aspirate fluids from high-risk patients. Breast Cancer Res Treat. 2004;84:99–105.

    Article  CAS  PubMed  Google Scholar 

  33. Zhu W, Qin W, Bradley P, et al. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. Carcinogenesis. 2005;26:145–52.

    Article  PubMed  Google Scholar 

  34. Jakupciak JP, Maggrah A, Maragh S, et al. Facile whole mitochondrial genome resequencing from nipple aspirate fluid using MitoChip v2.0. BMC Cancer. 2008;8:95.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Maitra A, Cohen Y, Gillespie SE, et al. The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection. Genome Res. 2004;14:812–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Wong LJ, Lueth M, Li XN, et al. Detection of mitochondrial DNA mutations in the tumor and cerebrospinal fluid of medulloblastoma patients. Cancer Res. 2003;63:3866–71.

    CAS  PubMed  Google Scholar 

  37. Kirches E, Krause G, Weis S, et al. Comparison between mitochondrial DNA sequences in low grade astrocytomas and corresponding blood samples. Mol Pathol. 2002;55:204–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Kirches E, Krause G, Warich-Kirches M, et al. High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int J Cancer. 2001;93:534–8.

    Article  CAS  PubMed  Google Scholar 

  39. Dakubo GD. Field cancerization: basic science and clinical applications. Hauppauge, NY: Nova Science; 2011.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Sciences Division Northern Ontario School of Medicine, West Campus, Lakehead University, Thunder Bay, Ontario, Canada

    Gabriel D. Dakubo

Authors
  1. Gabriel D. Dakubo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Dakubo, G.D. (2016). Mitochondrial Genome Changes as Cancer Biomarkers in Circulation. In: Cancer Biomarkers in Body Fluids. Springer, Cham. https://doi.org/10.1007/978-3-319-01580-4_7

Download citation

Publish with us

Policies and ethics

Search

Navigation